
Opinion|Videos|September 25, 2024
Type 2 Inflammation Biomarkers
Panelists discuss how biomarkers of type 2 inflammation, such as blood eosinophils, serum IgE, and fractional exhaled nitric oxide, can aid in diagnosing and monitoring type 2 inflammatory diseases as well as in predicting treatment response.
Advertisement
Episodes in this series

- What tests or biomarkers are used to determine if a patient’s disease may be caused by type 2 inflammation? How does this information aid your medication selection process?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
T-DXd Delivers Strong Breast Cancer Outcomes Across Groups
2
Experts Warn Binge Drinking Drives Early-Onset Breast Cancer, While Cessation Reduces Risk
3
Deprescribing Antidepressants Safely: New Evidence Supports Gradual Taper With Therapy
4
Breast Cancer Survivors Benefit From Tailored, Team-Based Menopause Care
5
















































